BIOLIFE SOLUTIONS INC Quarterly Depreciation in USD from Q1 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Biolife Solutions Inc quarterly/annual Depreciation history and growth rate from Q1 2011 to Q3 2024.
  • Biolife Solutions Inc Depreciation for the quarter ending September 30, 2024 was $600K, a 40% decline year-over-year.
  • Biolife Solutions Inc Depreciation for the twelve months ending September 30, 2024 was $2.8M, a 23.1% decline year-over-year.
  • Biolife Solutions Inc annual Depreciation for 2023 was $3.6M, a 9.09% increase from 2022.
  • Biolife Solutions Inc annual Depreciation for 2022 was $3.3M, a 13.8% increase from 2021.
  • Biolife Solutions Inc annual Depreciation for 2021 was $2.9M, a 107% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $2.8M $600K -$400K -40% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $3.2M $600K -$200K -25% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $3.4M $700K -$200K -22.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $3.6M $900K -$43K -4.56% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $3.64M $1M +$100K +11.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $3.54M $800K +$100K +14.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $3.44M $900K +$143K +18.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $3.3M $943K +$128K +15.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $3.17M $900K +$209K +30.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $2.96M $700K -$119K -14.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $3.08M $757K +$182K +31.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $2.9M $815K +$288K +54.6% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $2.61M $691K +$395K +133% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $2.22M $819K +$527K +180% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $1.69M $575K +$290K +102% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $1.4M $527K +$305K +137% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-31
Q3 2020 $1.1M $296K +$182K +160% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $913K $292K +$182K +165% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $731K $285K +$187K +191% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $544K $222K Oct 1, 2019 Dec 31, 2019 10-K 2022-03-31
Q3 2019 $114K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $110K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $98K +$20K +25.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-29
Q1 2018 $78K -$11.5K -12.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q1 2017 $89.5K -$2.24K -2.44% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q1 2016 $91.8K +$8.15K +9.74% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q1 2015 $83.6K +$21.1K +33.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q1 2014 $62.5K +$3.81K +6.49% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q1 2013 $58.7K +$32.2K +122% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q1 2012 $26.5K +$3.58K +15.7% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
Q1 2011 $22.9K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.